1. Congratulations to BoardProspects Member Ron Squarer on His Appointment to the Board of Retrophin (NASDAQ: RTRX)

    Congratulations to BoardProspects Member Ron Squarer on His Appointment to the Board of Retrophin (NASDAQ: RTRX)

    BoardProspects would like to congratulate its member Ron Squarer on his recent appointment to the Board of Directors of Retrophin, Inc. (NASDAQ: RTRX).  Mr. Squarer is chief executive officer and a director of Array BioPharma Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of targeted small molecule therapies.

    Retrophin is a fully integrated biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options.

     

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned